Holen Sie sich die Stockscreener-App
11.37
0.31%
0.02
Handel nachbörslich:
11.30
-0.07
-0.62%
Schlusskurs vom Vortag:
$11.35
Offen:
$11.32
24-Stunden-Volumen:
913.67K
Relative Volume:
1.32
Marktkapitalisierung:
$397.74M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-47.68M
KGV:
-4.0319
EPS:
-2.82
Netto-Cashflow:
$-31.31M
1W Leistung:
+5.42%
1M Leistung:
+5.03%
6M Leistung:
-1.77%
1J Leistung:
+30.41%
1-Tages-Spanne:
$11.29
$12.05
1-Wochen-Bereich:
$10.46
$12.05
52-Wochen-Spanne:
$8.77
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Vergleichen Sie DCTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
11.37 | 365.90M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Will Delcath Systems Inc. stock reach all time highs in 2025Buy Signal & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-13 22:29:23 - newser.com
Can technical indicators confirm Delcath Systems Inc.’s reversalJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com
Evaluating Delcath Systems Inc. with trendline analysisJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
What candlestick patterns are forming on Delcath Systems Inc.CEO Change & AI Driven Price Predictions - newser.com
Momentum divergence signals in Delcath Systems Inc. chart2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Is it time to cut losses on Delcath Systems Inc.Quarterly Trade Summary & Fast Entry High Yield Tips - newser.com
How to use a screener to detect Delcath Systems Inc. breakoutsWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
What to expect from Delcath Systems Inc. in the next 30 daysAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Tools to assess Delcath Systems Inc.’s risk profileWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Is Delcath Systems Inc a good long term investmentEconomic Data Impact & High Return Market Tips - earlytimes.in
What indicators show strength in Delcath Systems Inc.July 2025 Movers & Safe Capital Investment Plans - newser.com
Detecting price anomalies in Delcath Systems Inc. with AIWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Using Python tools to backtest Delcath Systems Inc. strategiesTrade Risk Report & Detailed Earnings Play Alerts - newser.com
What Fibonacci levels say about Delcath Systems Inc. rebound2025 Valuation Update & High Yield Stock Recommendations - newser.com
How to forecast Delcath Systems Inc. trends using time seriesEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
Delcath Systems (NASDAQ:DCTH) Given Hold (C-) Rating at Weiss Ratings - MarketBeat
Will Delcath Systems Inc. (DV3R) stock outperform Dow JonesWeekly Trade Recap & Breakout Confirmation Alerts - newser.com
Advanced analytics toolkit walkthrough for Delcath Systems Inc.Earnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Candlestick signals on Delcath Systems Inc. stock todayFed Meeting & Growth Focused Stock Pick Reports - newser.com
Why global investors buy Delcath Systems Inc. (DV3R) stock2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
What does recent volatility data suggest for Delcath Systems Inc.Market Risk Summary & Safe Entry Trade Signal Reports - newser.com
Delcath Systems (DCTH): Evaluating Valuation After CHOPIN Phase 2 Trial Results Announcement for Uveal Melanoma - Sahm
Delcath Systems Inc DV3R Stock Analysis and ForecastEconomic Data Impact & Use Smart Algorithms to Pick Better Stocks - earlytimes.in
Is Delcath Systems Inc. stock cheap at current valuationMarket Activity Report & Expert-Curated Trade Recommendations - newser.com
Pattern recognition hints at Delcath Systems Inc. upsideEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-05 05:55:28 - newser.com
Why Delcath Systems Inc. (DV3R) stock stays undervaluedInsider Buying & Free Technical Pattern Based Buy Signals - newser.com
What MACD signals say about Delcath Systems Inc.Trade Ideas & Real-Time Price Movement Reports - newser.com
Wall Street Zen Upgrades Delcath Systems (NASDAQ:DCTH) to “Buy” - Defense World
Wall Street Zen Upgrades Delcath Systems (NASDAQ:DCTH) to "Buy" - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Biliary Tract Cancer Market Expected to Gain Momentum Through 2034, According to DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai - Barchart.com
Biliary Tract Cancer Market Expected to Gain Momentum Through - openPR.com
Nkarta Inc Stock Analysis and ForecastPrice Support Zones & Exceptional Profit Trading - earlytimes.in
Delcath sets outlook amid plans to enter National Medicaid Drug Rebate Agreement - MSN
Delcath Systems Inc Stock Analysis and ForecastEarnings Growth Projections & Investment Risk Management Tips - earlytimes.in
United States Uveal Melanoma Treatment Market Set to Soar with - openPR.com
Is Delcath Systems Inc DV3R a good long term investmentHigh Yield Income Stocks & Your Roadmap to 10x Returns Starts Here - earlytimes.in
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):